COLOPLAST NAM. B DK 1 (CBHD) 50.96 EUR (+1.19%) | Healthcare & Biotechnology XETRA

Coloplast is a Danish company specializing in medical products and technologies for ongoing patient care, including urology, skin care, and ostomy care.

Comment

Performance & Momentum

6 Months 25.84 %

1 Year 14.76 %

3 Years 4.23 %

5 Years 16.05 %

Momentum

Unlock this indicator

Strategic Analysis

Coloplast occupies a defensive niche in medical technology, focused on chronic care and everyday-use devices for urology, ostomy care, and skin care. Its positioning is built on specialized, recurring, and hard-to-replace products, giving it better business visibility than many more cyclical healthcare players.

Strengths

Niche business with strong recurrence of patient needs and high barriers to entry
Defensive positioning supported by essential medical devices and limited exposure to consumer spending trade-offs
Recognized brand in specialized segments where the relationship with patients and healthcare professionals matters

Weaknesses

Recent stock market performance has deteriorated, signaling weakened market confidence despite the quality of the business model
Growth may depend more on commercial execution and incremental innovation than on major diversification drivers

Momentum

Momentum appears moderately positive in market terms, but it contrasts with a still-fragile recent trend over intermediate horizons. For an investor, this points to a quality stock that remains to be monitored in a recovery phase rather than a name with immediate strong acceleration.

Analysis performed 1 month ago